Tower Research Capital LLC TRC cut its stake in Stryker Corporation (NYSE:SYK) by 41.9% during the first quarter, Holdings Channel reports. The institutional investor owned 4,554 shares of the medical technology company’s stock after selling 3,287 shares during the period. Tower Research Capital LLC TRC’s holdings in Stryker Corporation were worth $599,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Macquarie Group Ltd. raised its stake in Stryker Corporation by 13.3% in the fourth quarter. Macquarie Group Ltd. now owns 103,000 shares of the medical technology company’s stock valued at $12,341,000 after buying an additional 12,100 shares in the last quarter. Lynch & Associates IN raised its stake in Stryker Corporation by 0.3% in the first quarter. Lynch & Associates IN now owns 27,450 shares of the medical technology company’s stock valued at $3,614,000 after buying an additional 75 shares in the last quarter. Koshinski Asset Management Inc. raised its stake in Stryker Corporation by 428.5% in the first quarter. Koshinski Asset Management Inc. now owns 15,991 shares of the medical technology company’s stock valued at $2,105,000 after buying an additional 12,965 shares in the last quarter. National Pension Service raised its stake in Stryker Corporation by 0.4% in the first quarter. National Pension Service now owns 245,638 shares of the medical technology company’s stock valued at $32,412,000 after buying an additional 884 shares in the last quarter. Finally, LVM Capital Management Ltd. MI raised its stake in Stryker Corporation by 0.7% in the first quarter. LVM Capital Management Ltd. MI now owns 29,520 shares of the medical technology company’s stock valued at $3,886,000 after buying an additional 207 shares in the last quarter. Institutional investors own 73.99% of the company’s stock.

Shares of Stryker Corporation (SYK) traded up 0.41% on Friday, reaching $144.50. 262,257 shares of the company were exchanged. The company’s 50-day moving average price is $143.63 and its 200 day moving average price is $135.35. Stryker Corporation has a 12 month low of $106.48 and a 12 month high of $148.84. The company has a market cap of $54.05 billion, a price-to-earnings ratio of 32.25 and a beta of 0.80.

Stryker Corporation (NYSE:SYK) last announced its earnings results on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. The company had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The firm’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.39 earnings per share. On average, equities research analysts expect that Stryker Corporation will post $6.50 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be paid a $0.425 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.70 annualized dividend and a yield of 1.18%. Stryker Corporation’s payout ratio is 37.95%.

COPYRIGHT VIOLATION WARNING: “Stryker Corporation (NYSE:SYK) Shares Sold by Tower Research Capital LLC TRC” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/08/11/stryker-corporation-nysesyk-shares-sold-by-tower-research-capital-llc-trc.html.

SYK has been the topic of several research analyst reports. Jefferies Group LLC restated a “hold” rating and issued a $132.00 price target on shares of Stryker Corporation in a research report on Thursday, April 13th. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $148.00 price objective on shares of Stryker Corporation in a report on Monday, April 17th. Needham & Company LLC reaffirmed a “sell” rating on shares of Stryker Corporation in a report on Wednesday, April 26th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $140.00 price objective (up from $135.00) on shares of Stryker Corporation in a report on Wednesday, April 26th. Finally, Cowen and Company set a $150.00 price objective on shares of Stryker Corporation and gave the stock an “outperform” rating in a report on Wednesday, April 26th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and twelve have issued a buy rating to the stock. Stryker Corporation has a consensus rating of “Hold” and an average target price of $144.03.

In related news, insider David Floyd sold 19,305 shares of the company’s stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total value of $2,790,730.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Graham A. Mclean sold 1,124 shares of the company’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the sale, the insider now directly owns 8,983 shares in the company, valued at $1,313,853.58. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 32,810 shares of company stock worth $4,754,958. 7.40% of the stock is owned by insiders.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.